Previous endotracheal aspirate allows guiding the initial treatment of ventilator-associated pneumonia

Intensive Care Medicine

Volumn 35, Issue 1, 2009, Pages 101-107

  Jung, Boris ^a   Sebbane, Mustapha ^a   Chanques, Gerald ^a   Courouble, Patricia ^a   Verzilli, Daniel ^a   Perrigault, Pierre François ^a   Jean Pierre, Helene ^b   Eledjam, Jean Jacques ^a   Jaber, Samir ^a  

^a HÔPITAL SAINT ELOI   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Antibiotic therapy; Broncho alveolar lavage; Endotracheal aspiration; Mechanical ventilation; Nosocomial pneumonia; Ventilator associated pneumonia

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; FEMALE; HUMAN; INFORMATION PROCESSING; INTENSIVE CARE UNIT; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; TRACHEAL ASPIRATION PROCEDURE; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; COHORT STUDIES; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE COCCI; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TRACHEA;

EID: 58549095637     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-008-1248-8     Document Type: Article

References (28)

1. American Thoracic Society; Infectious Diseases Society of America 2005 Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 171 388 416
2. JY Fagon J Chastre AJ Hance P Montravers A Novara C Gibert 1993 Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay Am J Med 94 281 288
3. L Papazian F Bregeon X Thirion R Gregoire P Saux JP Denis G Perin J Charrel JF Dumon JP Affray F Gouin 1996 Effect of ventilator-associated pneumonia on mortality and morbidity Am J Respir Crit Care Med 154 91 97
4. J Valles A Pobo O Garcia-Esquirol D Mariscal J Real R Fernandez 2007 Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset Intensive Care Med 33 1363 1368
5. J Rello DA Ollendorf G Oster M Vera-Llonch L Bellm R Redman MH Kollef 2002 Epidemiology and outcomes of ventilator-associated pneumonia in a large US database Chest 122 2115 2121
6. MJ Richards JR Edwards DH Culver RP Gaynes 1999 Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System Crit Care Med 27 887 892
7. DK Warren SJ Shukla MA Olsen MH Kollef CS Hollenbeak MJ Cox MM Cohen VJ Fraser 2003 Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center Crit Care Med 31 1312 1317
8. H Dupont H Mentec JP Sollet G Bleichner 2001 Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia Intensive Care Med 27 355 362
9. DK Heyland DJ Cook L Griffith SP Keenan C Brun-Buisson 1999 The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group Am J Respir Crit Care Med 159 1249 1256
10. MH Kollef 1999 The prevention of ventilator-associated pneumonia N Engl J Med 340 627 634
11. MH Kollef VJ Fraser 2001 Antibiotic resistance in the intensive care unit Ann Intern Med 134 298 314
12. F Michel B Franceschini P Berger JM Arnal M Gainnier JM Sainty L Papazian 2005 Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures Chest 127 589 597
13. B Jung S Jaber P Perrigault M Sebbane D Verzilli H Jeanpierre J Eledjam 2006 Weekly systematic endotracheal aspiration allows early and adequate antibiotic therapy for VAP Intensive Care Med 32 S102
14. L Papazian C Martin B Meric JF Dumon F Gouin 1993 A reappraisal of blind bronchial sampling in the microbiologic diagnosis of nosocomial bronchopneumonia. A comparative study in ventilated patients Chest 103 236 242
15. B Souweine B Veber JP Bedos B Gachot MC Dombret B Regnier M Wolff 1998 Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments Crit Care Med 26 236 244
16. JR Le Gall S Lemeshow F Saulnier 1993 A new simplified acute physiology score (SAPS II) based on a european/north American multicenter study JAMA 270 2957 2963
17. JL Vincent R Moreno J Takala S Willatts A De Mendonca H Bruining CK Reinhart PM Suter LG Thijs 1996 The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine Intensive Care Med 22 707 710
18. J Pugin R Auckenthaler N Mili JP Janssens PD Lew PM Suter 1991 Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid Am Rev Respir Dis 143 1121 1129
19. JM Sirvent A Torres L Vidaur J Armengol J de Batlle A Bonet 2000 Tracheal colonisation within 24 h of intubation in patients with head trauma: risk factor for developing early-onset ventilator-associated pneumonia Intensive Care Med 26 1369 1372
20. J Hayon C Figliolini A Combes JL Trouillet N Kassis MC Dombret C Gibert J Chastre 2002 Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia Am J Respir Crit Care Med 165 41 46
21. P Depuydt D Benoit D Vogelaers J Decruyenaere D Vandijck G Claeys G Verschraegen S Blot 2008 Systematic surveillance cultures as a toolto predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia Intensive Care Med 34 4 675 682
22. J Chastre 2005 Antibiotic prescribing for ventilator-associated pneumonia: get it right from the beginning but be able to rapidly deescalate Intensive Care Med 31 1463 1465
23. E Giantsou N Liratzopoulos E Efraimidou M Panopoulou E Alepopoulou S Kartali-Ktenidou GI Minopoulos S Zakynthinos KI Manolas 2005 Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria Intensive Care Med 31 1488 1494
24. J Rello E Diaz M Roque J Valles 1999 Risk factors for developing pneumonia within 48 hours of intubation Am J Respir Crit Care Med 159 1742 1746
25. A Combes CE Luyt JY Fagon M Wolff JL Trouillet J Chastre 2006 Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia Intensive Care Med 32 1970 1978
26. EH Ibrahim G Sherman S Ward VJ Fraser MH Kollef 2000 The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting Chest 118 146 155
27. M Leone A Bourgoin S Cambon M Dubuc J Albanese C Martin 2003 Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome Crit Care Med 31 462 467
28. MP Young HL Manning DL Wilson SA Mette RR Riker JC Leiter SK Liu JT Bates PE Parsons 2004 Ventilation of patients with acute lung injury and acute respiratory distress syndrome: has new evidence changed clinical practice? Crit Care Med 32 1260 1265